CSIMarket
 


Becton Dickinson And Company  (NYSE: BDX)
Other Ticker:  
 
 

BDX's Revenue Growth by Quarter and Year

Becton Dickinson And's Revenue results by quarter and year

 



BDX Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter September - 5,437.00 5,087.00 4,223.00
3rd Quarter June - 4,990.00 4,878.00 4,641.00
2nd Quarter March 5,272.00 5,045.00 4,821.00 5,011.00
1st Quarter December 5,168.00 4,706.00 4,586.00 4,995.00
FY   10,440.00 20,178.00 19,372.00 18,870.00

BDXs Annual Revenue
Becton Dickinson And's Revenue in the fiscal year 2024 $ 20,178.00 millions
Becton Dickinson And's Revenue in the fiscal year 2023 $ 19,372.00 millions
Becton Dickinson And's Revenue in the fiscal year 2022 $ 18,870.00 millions
Becton Dickinson And's Revenue in the fiscal year 2021 $ 20,248.00 millions
Becton Dickinson And's Revenue in the fiscal year 2020 $ 17,117.00 millions




BDX Revenue second quarter 2025 Y/Y Growth Comment
Becton Dickinson And Company reported Revenue growth of 4.5% year on year in the second quarter 2025, to $ 5,272.00 millions, this is lower than Becton Dickinson And Company's recent average Revenue growth of 6.86%.

Looking into second quarter 2025 results within Medical Equipment & Supplies industry 34 other companies have achieved higher Revenue growth. While Becton Dickinson And Company' s Revenue increase of 4.5% ranks overall at the positon no. 771 in the second quarter 2025.




BDX Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter September - 6.88 % 20.46 % -17.78 %
3rd Quarter June - 2.3 % 5.11 % -5.09 %
2nd Quarter March 4.5 % 4.65 % -3.79 % 2.12 %
1st Quarter December 9.82 % 2.62 % -8.19 % -6.02 %
FY   - 4.16 % 2.66 % -6.81 %

Financial Statements
Becton Dickinson And's second quarter 2025 Revenue $ 5,272.00 millions BDX's Income Statement
Becton Dickinson And's second quarter 2024 Revenue $ 5,045.00 millions Quarterly BDX's Income Statement


BDX Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter September - 8.96 % 4.28 % -9.01 %
3rd Quarter June - -1.09 % 1.18 % -7.38 %
2nd Quarter March 2.01 % 7.2 % 5.12 % 0.32 %
1st Quarter December -4.95 % -7.49 % 8.6 % -2.75 %
FY (Year on Year)   - 4.16 % 2.66 % -6.81 %




Revenue second quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #35
Healthcare Sector #105
Overall #771

Revenue Y/Y Growth Statistics
High Average Low
68.82 % 6.86 % -15.35 %
(March 31, 2016)   (Jun 30 2017)
Revenue second quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #35
Healthcare Sector #105
Overall #771
Revenue Y/Y Growth Statistics
High Average Low
68.82 % 6.86 % -15.35 %
(March 31, 2016)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Becton Dickinson And's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
63.81 % 2.4 % -41.58 %
(Sep 30 2015)  


BDX's II. Quarter Q/Q Revenue Comment
Becton Dickinson And Company achieved in the II. Quarter 2025 below company average Revenue growth of 2.01% quarter on quarter, to $ 5,272.00 millions.

Within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Becton Dickinson And's Revenue growth quarter on quarter, overall rank is 413.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #45
Overall #413
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #45
Overall #413
Revenue Q/Q Growth Statistics
High Average Low
63.81 % 2.4 % -41.58 %
(Sep 30 2015)  


BDX's II. Quarter Q/Q Revenue Comment
Becton Dickinson And Company achieved in the II. Quarter 2025 below company average Revenue growth of 2.01% quarter on quarter, to $ 5,272.00 millions.

Within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Becton Dickinson And's Revenue growth quarter on quarter, overall rank is 413.


Becton Dickinson And's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
Cumulative Revenue 12 Months Ending $ 20,867.00 $ 20,640.00 $ 20,178.00 $ 19,828.00 $ 19,716.00
Y / Y Revenue Growth (TTM) 5.84 % 5.89 % 4.16 % 7.13 % 7.91 %
Year on Year Revenue Growth Overall Ranking # 453 # 246 # 1501 # 743 # 744
Seqeuential Revenue Change (TTM) 1.1 % 2.29 % 1.77 % 0.57 % 1.15 %
Seq. Revenue Growth (TTM) Overall Ranking # 771 # 321 # 1487 # 547 # 1716


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2025 period, Becton Dickinson And's cumulative twelve months Revenue were $ 20,867 millions, company would post below average annual Revenue growth of 1.15% year on year, if the fiscal year would end at Mar 31 2025.
A slow-down in the Becton Dickinson And's Revenue growth from the 5168% growth in Dec 31 2024.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 246 to 453.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 77
Overall # 453

Revenue TTM Y/Y Growth Statistics
High Average Low
68.82 %
6.86 %
-15.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 105
S&P 500 # 771
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2025 period, Becton Dickinson And's cumulative twelve months Revenue were $ 20,867 millions, company would post below average annual Revenue growth of -15.35% year on year, if the fiscal year would end at Mar 31 2025.
A slow-down in the Becton Dickinson And's Revenue growth from the 5168% growth in Dec 31 2024.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 246 to 453.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 77
Overall # 453

Revenue TTM Y/Y Growth Statistics
High Average Low
68.82 %
6.86 %
-15.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 105
S&P 500 # 771




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BDX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BDX's Competitors
Revenue Growth for Becton Dickinson And's Suppliers
Revenue Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2025
Livanova Plc7.60%$ 7.604 millions
Tela Bio Inc 7.20%$ 7.199 millions
Corcept Therapeutics Inc7.09%$ 7.088 millions
Prestige Consumer Healthcare Inc 6.91%$ 6.909 millions
Recursion Pharmaceuticals Inc 6.89%$ 6.894 millions
Outset Medical Inc 6.80%$ 6.801 millions
Icu Medical Inc6.69%$ 6.687 millions
Universal Health Services Inc 6.66%$ 6.664 millions
Agios Pharmaceuticals Inc 6.56%$ 6.558 millions
Biogen Inc 6.13%$ 6.134 millions
Healthcare Services Group Inc 5.72%$ 5.722 millions
Integer Holdings Corporation5.67%$ 5.673 millions
Hca Healthcare Inc 5.66%$ 5.664 millions
Personalis Inc 5.53%$ 5.531 millions
Inogen Inc 5.45%$ 5.453 millions
Amneal Pharmaceuticals Inc 5.44%$ 5.437 millions
Vanda Pharmaceuticals Inc 5.43%$ 5.434 millions
Labcorp Holdings Inc 5.30%$ 5.304 millions
Puma Biotechnology Inc 5.12%$ 5.120 millions
Liquidia Corporation4.98%$ 4.980 millions
Bausch Health Companies Inc 4.92%$ 4.923 millions
Exagen Inc 4.91%$ 4.912 millions
Mimedx Group Inc 4.69%$ 4.688 millions
Becton Dickinson And Company4.50%$ 4.500 millions
Inotiv Inc 4.44%$ 4.442 millions
Supernus Pharmaceuticals inc 4.30%$ 4.302 millions
Brookdale Senior Living Inc 3.96%$ 3.964 millions
Abbott Laboratories3.95%$ 3.954 millions
Integra Lifesciences Holdings Corp3.74%$ 3.736 millions
Idexx Laboratories Inc3.56%$ 3.559 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com